How is fungal rhinosinusitis classified?

Classification of Fungal Rhinosinusitis

Fungal rhinosinusitis is classified into two major categories based on tissue invasion: non-invasive forms (fungal ball and allergic fungal rhinosinusitis) and invasive forms (acute, chronic, and chronic granulomatous invasive fungal rhinosinusitis), with the host immune status being the primary determinant of disease type. 1

Primary Classification Framework

The classification system divides fungal rhinosinusitis based on whether fungal hyphae invade into mucosal tissue 1:

Non-Invasive Forms

1. Fungal Ball

• Fungal concretion or collection within a single sinus (typically maxillary or sphenoid)
• No tissue invasion by fungal hyphae
• Occurs in immunocompetent patients
• Previously termed "mycetoma" or "aspergilloma" (terms now discouraged) 1
• Represents a foreign body-type reaction 1

2. Allergic Fungal Rhinosinusitis (AFRS)

• Characterized by eosinophilic mucin with non-invasive fungal hyphae
• Type I hypersensitivity reaction to fungi
• Occurs in immunocompetent, atopic patients
• Requires fungal sensitization as primary feature 1
• Accounts for 5-10% of chronic rhinosinusitis cases 1

Invasive Forms

All invasive forms are defined by fungal hyphae seen 'within' mucosal tissue, demonstrating angio-invasion or other infiltrative patterns 1:

1. Acute Invasive Fungal Rhinosinusitis (AIFRS)

• Duration less than 4 weeks 1, 2
• Almost exclusively in immunocompromised patients
• Most common pathogens: Zygomycetes (Rhizopus, Mucor, Rhizomucor) and Aspergillus species 1
• Characterized by angioinvasion causing thrombosis, mucosal infarction, and tissue necrosis 1

2. Chronic Invasive Fungal Rhinosinusitis (CIFRS)

• Duration greater than 12 weeks 1
• Locally invasive disease in immunocompromised patients
• Less fulminant course than acute form

3. Chronic Granulomatous Invasive Fungal Rhinosinusitis (CGFRS)

• Low-grade submucosal granulomatous inflammation with diffuse fibrosis
• Limited fungal elements
• Can occur in immunocompetent hosts (mainly reported from India) 1
• Duration greater than 3 months 2

Key Diagnostic Distinctions

Critical Histopathologic Criteria

For invasive disease, two criteria must be met 1:

1. Rhinosinusitis confirmed by radiological imaging or tissue destruction
2. Histopathological evidence of hyphal forms within sinus mucosa, submucosa, blood vessels, or bone

Host Immune Status as Primary Determinant

The host immune state determines clinical presentation rather than the fungal species itself 1:

• Immunocompetent patients: Develop fungal ball or AFRS
• Immunocompromised patients: Develop invasive forms
  • Diabetes (50%) and hematologic malignancy (40%) account for 90% of invasive cases 1
  • Other risk factors: neutropenia, HIV/AIDS, iron overload, protein-energy malnutrition, transplant patients on azole prophylaxis 1

Fungal Morphology Differences

Aspergillus species: Uniform width, acute-branching septate (dichotomous) hyphae, branching at approximately 45 degrees 1

Zygomycetes: Non-septate hyphae with wide-angle branching 1

Important Clinical Caveats

Temporal classification controversy: While some divide invasive disease into acute (<4 weeks) versus chronic (>4 weeks), the type of fungus and degree of immunosuppression create these differences—thus all are considered forms of "invasive fungal rhinosinusitis" for classification purposes 1

AFRS diagnostic requirements (Bent-Kuhn criteria) 1:

1. Nasal polyposis
2. Fungi on staining
3. Eosinophilic mucin without fungal invasion
4. Type I hypersensitivity to fungi
5. Characteristic CT findings with soft tissue differential densities

Critical distinction: The presence of fungi alone does not define the disease category—fungi can be found in healthy sinuses 1. The classification depends on invasion status, immune response pattern, and host factors.